Your account is not claimed yet. You can sign up with ORCID to claim your account.

Shelley N Facente (Shelley Facente, S N Facente)

ORCID

Publication Activity (10 Years)

Years Active: 2018-2023
Publications (10 Years): 15

Top Venues

PloS one

Drugs

Gates open research

JMIR public health and surveillance

Vitalant Research Institute

University of California, Berkeley (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Vitalant Research Institute Dec 1o 2017

United States

Affiliate Investigator

Education History

University of California, Berkeley Aug 28o 2018

United States

PHD :: Epidemiology

Publications

Lauren A Hunter, Stacia K Wyman, Laura J Packel, Shelley N Facente, Yi Li, Anna Harte, Guy Nicolette, null null, Clara DiGermanio, Michael P Busch, Arthur L Reingold, Maya L Petersen
Monitoring SARS-CoV-2 incidence and seroconversion among university students and employees: a longitudinal cohort study in California, June-August 2020. BMJ open 13 (4) (2023)
Eric J Lenze, Angela M Reiersen, Shelley N Facente
Authors' Reply to Mazza et al.: "Fluvoxamine for the Early Treatment of SARS‑CoV‑2 Infection: A Review of Current Evidence". Drugs 82 (3) (2022)
Shelley N Facente, Mariah De Zuzuarregui, Darren Frank, Sarah Gomez-Aladino, Ariel Muñoz, Sabrina Williamson, Emily Wang, Lauren A Hunter, Laura Packel, Arthur Reingold
Anticipated and Experienced Stigma After Testing Positive for SARS-CoV-2: A Qualitative Study. Health promotion practice (2022)
Dharma N Bhatta, Jennifer Hecht, Shelley N Facente
Factors associated with stigma related to HIV pre-exposure prophylaxis (PrEP) use among men who have sex with men (MSM). Sexually transmitted infections 98 (8) (2022)
Shelley N Facente, Eduard Grebe, Andrew D Maher, Douglas Fox, Susan Scheer, Mary I Mahy, Shona Dalal, David W Lowrance, Kimberly Marsh
Use of HIV Recency Assays for HIV Incidence Estimation and Other Surveillance Use Cases: Systematic Review. JMIR public health and surveillance 8 (3) (2022)
Shelley N Facente, Rachel Grinstein, Roberta L Bruhn, Zhanna Kaidarova, Erin Wilson, Jennifer Hecht, Katie Burk, Eduard Grebe, Meghan D Morris
Hepatitis C prevalence and key population size estimate updates in San Francisco: 2015 to 2019. PloS one 17 (5) (2022)
Shelley N Facente, Rachel Grinstein, Janessa Broussard, Jessica Shost, Soraya Azari, Jennifer Siruno, Jose A Jimenez, Anne F Luetkemeyer, Katie Burk
Hepatitis C Elimination During a Global Pandemic: A Case Study of Resilience in Action. Public health reports (Washington, D.C. : 1974) 137 (4) (2022)
Shelley N Facente, Angela M Reiersen, Eric J Lenze, David R Boulware, Jeffrey D Klausner
Fluvoxamine for the Early Treatment of SARS-CoV-2 Infection: A Review of Current Evidence. Drugs 81 (18) (2021)
Laura J Packel, Arthur Reingold, Lauren Hunter, Shelley N Facente, Yi Li, Anna Harte, Guy Nicolette, Fyodor D Urnov, Michael Lu, Maya Petersen, null null
Piloting an integrated SARS-CoV-2 testing and data system for outbreak containment among college students: A prospective cohort study. PloS one 16 (1) (2021)
Dharma N Bhatta, Jennifer Hecht, Shelley N Facente
Psychosocial Determinants of HIV Stigma among Men Who Have Sex with Men in San Francisco, California. International journal of environmental research and public health 18 (15) (2021)
Sarah R Ahmad, Tessnim R Ahmad, Vidhya Balasubramanian, Shelley N Facente, Cindy Kin, Sabine Girod
Are You Really the Doctor? Physician Experiences with Gendered Microaggressions from Patients. Journal of women's health (2002) (2021)
Shelley N Facente, E Grebe, C D Pilcher, M P Busch, G Murphy, A Welte
Estimated dates of detectable infection (EDDIs) as an improvement upon Fiebig staging for HIV infection dating. Epidemiology and infection 148 (2020)
Shelley N Facente, Michael P Busch, Eduard Grebe, Christopher D Pilcher, Alex Welte, Brian Rice, Gary Murphy
Challenges to the performance of current HIV diagnostic assays and the need for centralized specimen archives: a review of the Consortium for the Evaluation and Performance of HIV Incidence Assays (CEPHIA) repository. Gates open research 3 (2019)
Joseph B Sempa, Alex Welte, Michael P Busch, Jake Hall, Dylan Hampton, Shelley N Facente, Sheila M Keating, Kara Marson, Neil Parkin, Christopher D Pilcher, Gary Murphy, Eduard Grebe, null null
Performance comparison of the Maxim and Sedia Limiting Antigen Avidity assays for HIV incidence surveillance. PloS one 14 (7) (2019)
Shelley N Facente, Eduard Grebe, Katie Burk, Meghan D Morris, Edward L Murphy, Ali Mirzazadeh, Aaron A Smith, Melissa A Sanchez, Jennifer L Evans, Amy Nishimura, Henry F Raymond, null null
Estimated hepatitis C prevalence and key population sizes in San Francisco: A foundation for elimination. PloS one 13 (4) (2018)

Shelley N Facente.css-eqlu8i{font-size:small;padding-left:4px;} (Shelley Facente, S N Facente)

Publication Activity (10 Years)

Top Topics

Top Venues

Shelley N Facente (Shelley Facente, S N Facente)